Insights On Trial Design

  1. Orphan Indications and Clinical Trials - Recruiting

    Look at ways to proactively recruit so as to overcome challenges.

  2. Orphan Indications and Clinical Trials - Why Rare Diseases Warrant Special Treatment

    Unique characteristics of clinical trials for chronic, rare diseases.

  3. Cellular Therapy Studies: 7 Common Challenges

    Cellular therapy is a form of treatment where patients are injected with cellular material. Different types of cells can be utilized such as stem cells (such as mesenchymal stem cells) and cells from the immune system (such as regulatory T cells (Tregs)) from either the patient or a donor.

  4. New Opportunities For Immuno-oncology Clinical Development Programs Through T Cell/B Cell Repertoire Profiling

    Immune repertoire profiling provides better outcomes for immuno-oncology development programs .

  5. New Packaging Strategy Optimizes Supplies And Prevents Break In Enrollment

    Direction from a solution provider with expertise in forecasting, packaging, labeling and distribution along with services of an IRT provider solves drug shortage challenge.

  6. Rein In The High Cost Of Cardiovascular Outcome Trials

    Three success factors for leaner operations.

  7. Analytics And Metrics Help Pinpoint Costs Of Study Startup

    Learn how by embracing a systematic, data-driven approach, it is possible for metrics to identify more accurately the best sites, steps causing delays, the associated costs, and why this is happening.

  8. Companion Diagnostic Development: Current Trends And Recommendations

    Learn six strategies for success when developing your companion diagnostic.

  9. Age Diversity In Clinical Trials: Addressing The Unmet Need

    In a recent New York Times article, Paula Span raises the concern that elderly subjects are frequently omitted from clinical trials.  Consequently, physicians know very little about how a given treatment may affect their older patients.  Is a medication effective for the elderly?  Is it safe?  Without data, how is a physician to know?  

  10. The Importance Of Real World Evidence In Oncology

    There is a significant need to collect Real World Evidence (RWE) to demonstrate the benefit of these drugs in clinical practice which can then be used as the wrap around to demonstrate true clinical benefit and address all stakeholder needs.